MedTrace Logo

Ambulatory Long Length URodynamics Evaluation

NCT07425015 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2026-04-15

No results posted yet for this study

Summary

A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary tract using the Glean Urodynamics System.

Conditions

  • Urology
  • Urinary Bladder, Overactive
  • Benign Prostatic Hyperplasia
  • Urodynamics
  • Home Monitoring
  • Urinary Incontinence (UI)
  • Lower Urinary Tract Dysfunction

Interventions

DEVICE

Glean Urodynamics System

Glean Urodynamics System including a bladder pressure sensor, abdominal pressure sensor, uroflowmeter, and software apps.

Sponsors & Collaborators

  • Bright Uro

    lead INDUSTRY

Principal Investigators

  • Brittany Carter, DHSc, MPH · Bright Uro

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-17
Primary Completion
2027-06-30
Completion
2027-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07425015 on ClinicalTrials.gov